SLB vs TMO: Which Is the Better Buy?
Side-by-side comparison of SLB N.V. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
SLB N.V. · Energy
$48.09
-33.4% upside to fair value
Grade C
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
SLB trades at a lower forward P/E
(21.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
SLB |
TMO |
| Current Price |
$48.09 |
$464.61 |
| Fair Value Estimate |
$32.01 |
$498.27 |
| Upside to Fair Value |
-33.4%
|
+7.2%
|
| Market Cap |
$71.9B |
$172.7B |
| Forward P/E |
21.8x
|
25.2x
|
| EV / EBITDA |
10.9x
|
19.1x
|
| Price / Sales |
2.0x
|
3.8x
|
| Price / FCF |
15.4x
|
25.6x
|
| Revenue Growth YoY |
+2.7%
|
+6.2%
|
| Gross Margin |
17.3%
|
39.4%
|
| Operating Margin |
14.4%
|
17.8%
|
| Return on Equity |
13.5%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.51%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
SLB N.V. is a global leader in oilfield services, specializing in well construction, production systems, reservoir performance, and digital solutions. The company benefits from a durable competitive moat anchored in technology, integrated service breadth, and global infrastructure, with a management team that has long tenure and deep industry experience. Despite solid free cash flow generation of…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
SLB |
TMO |
| Zone Low |
$24.01 |
$373.70 |
| Zone High |
$27.21 |
$423.53 |
| In Buy Zone? |
No
|
No
|